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The mechanism and machinery of hepatitis C virus (HCV) RNA replication are still poorly characterized. Our previous study has shown
that HCV RNA synthesis occurs on a lipid raft membrane structure [J. Virol. 77 (2003) 77 4160]. In this study, we further characterized these
replication complexes (RCs) in Huh-7 cells that support active RNA replication of a subgenomic HCV replicon. Biochemical analysis
showed that these membrane structures were resistant to Nonidet P-40 or Triton X-100 (TX-100) at 4 jC while solubilized by h-
octylglucoside at 4 jC or Triton TX-100 at 37 jC, characteristic of lipid rafts. Cholesterol sequestration assay further demonstrated the
association between HCV nonstructural (NS) proteins and cholesterol-rich lipid rafts. The RCs contained both minus- and plus-strand HCV
RNA, with the plus-stranded RNA being approximately 10-fold more abundant than the minus-strand. Furthermore, the HCV RNA and NS
proteins were resistant to RNase and protease digestion, respectively, but became sensitive after treatment with the raft-disrupting agents.
These results suggested that the HCV RCs are protected within lipid rafts. Detergent-resistant membrane (DRM) fractions containing NS
proteins and viral RNA were capable of HCV RNA synthesis using the endogenous HCV RNA template. NS proteins were distributed in
both the ER and the Golgi, but the majority of the active RCs were detected in the Golgi-derived membrane. Depletion of cellular cholesterol
selectively reduced HCV RNA replication. These findings provide further insights into the mechanism of HCV replication in vivo.
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Introduction HCV subgenomic replicon cell culture system (Lohmann etHepatitis C virus (HCV) is a major causative agent of
chronic hepatitis, liver cirrhosis, and hepatocellular carcino-
ma. Blood screening based on the cloned HCV genome and
its gene products has reduced significantly the blood-borne
HCV transmission (Choo et al., 1989; Kuo et al., 1989; Saito
et al., 1990). However, detailed studies of HCV (e.g., virus
replication, pathogenicity, and natural history of HCV) have
been greatly hampered by the lack of efficient in vitro culture
systems of HCV infection. Recently, the establishment of an0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.03.034
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E-mail address: michlai@usc.edu (M.M.C. Lai).al., 1999) has enabled the studies of HCV RNA replication.
This system has demonstrated that HCV RNA replication
requires only the viral nonstructural NS proteins, NS3,
NS4A, NS4B, NS5A and NS5B. But the detailed mechanism
of HCV replication is yet to be characterized.
RNA replication of most RNA viruses involves certain
intracellular membrane structure, including the ER
(Restrepo-Hartwig and Ahlquist, 1996; Schaad et al.,
1997; Van der Meer et al., 1998), Golgi (Shi et al.,
1999), endosomes, and lysosomes (Froshauer et al.,
1988). Recently, several groups have succeeded in show-
ing the in vitro replication activities of the replication
complexes (RCs) in crude membrane fractions of the
HCV subgenomic replicon cells (Ali et al., 2002; Hardy
et al., 2003; Lai et al., 2003). These crude cell-free systems
provide a valuable complement to the in vitro polymerase
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and a useful source for isolation of viral RCs. However,
the nature of these RCs has not been well characterized.
Recently, we have demonstrated that newly synthesized
HCV RNA and the NS proteins colocalized with each other
on distinct speckle-like structures in the cytoplasm of the
replicon cell lines (Shi et al., 2003). Membrane flotation
analysis further demonstrated that HCV RNA and NS
proteins were present in detergent-resistant membrane
(DRM) structures, most likely a lipid-raft structure. Lipid
rafts are microdomains that are enriched in cholesterol and
sphingolipid (Simons and Ikonen, 1997, 2000; Simons and
Toomre, 2000). Lipid rafts are characterized biochemically
by their insolubility in detergents, and are known to play a
critical role in many biological processes such as regulators
and organizing centers of signal transduction and membrane
traffic pathways. Recent studies also demonstrated that
many infectious agents, including viruses, bacteria, and
parasites, utilize rafts to populate in the host cells (Fivaz
et al., 1999).
In this study, we characterized the structure of the HCV
RCs with an intact replication activity. We established that
the active RCs, which consist of lipid rafts, existed in the
Golgi-derived membrane. These studies provide important
insights into the mechanism of RNA replication and
pathogenesis of HCV and also suggest potential inhibitors
targeting HCV RNA replication.Results
Association of HCV NS proteins with DRM fractions
Previous studies on the HCV replicon cells have shown
that the majority of HCV NS proteins were detected in
membrane fractions (Bartenschlager and Lohmann, 2000).
Shi et al. (2003) also suggested that the newly synthesizedFig. 1. Detection of HCV proteins in DRM fractions of HCV replicon cells. Cell ly
fractionated by discontinuous sucrose gradient centrifugation. Each fraction was c
YM-30 was used. Equal volumes of the recovered fractions were analyzed on a 1
NS5A, NS5B, Calnexin, or Cav-2. Fractions are numbered from 1 to 9 in orderHCV RNA was present in the same membrane fractions.
These findings provide strong evidence that HCV replica-
tion occurs through membrane-associated RCs, as is the
case of several other positive-strand RNA viruses, including
poliovirus, flavivirus, and flock house virus (Bolten et al.,
1998; Westaway et al., 1997).
Furthermore, our data suggested that the HCV RCs were
resistant to detergent [1% Nonidet P-40 (NP-40) at 4 jC]
treatment. To further characterize the nature of the DRM
fraction containing HCV RC, we performed additional
membrane flotation analysis of the lysates of the HCV
replicon cells under a different condition. In this experiment,
each sucrose fraction was concentrated by passing through a
Centriplus YM-100 filter unit, which allows free HCV NS
proteins (< 100000 Da) to go through. Thus, only those
proteins existing in large complexes could be detected. As
shown in Fig. 1, NS3, NS5A, and NS5B were found almost
completely in the membrane fraction. When the cell lysates
were treated with 1% NP-40, a nonionic detergent, on ice, a
condition which released the ER transmembrane protein
calnexin to the cytosol, most of the HCV proteins remained
in the membrane fractions. Previously, Shi et al. (2003) has
shown that by using a Centricon YM-10 filter unit, which
detected all the individual HCV NS protein (>10000 Da),
only a small percentage of the NS5A protein and more than
half of NS5B were detected in the cytosolic fractions after
NP-40 treatment. These results combined indicated that
most of the NS3, NS5A, and NS5B in the DRM were
present as large complexes, which could be partially disso-
ciated after treatment with the detergent.
To characterize the nature of these DRM fractions, we
examined Caveolin-2 (Cav-2), which is localized in plasma
membrane caveolae and associated with lipid rafts (Fujimoto
et al., 2001; Ostermeyer et al., 2001; Pol et al., 2001). Cav-2
was present mostly in the DRM fractions, similar to the
distribution of NS3, NS5A, and NS5B. These results indicate
that the NS proteins are associated with the DRM structuressates were either untreated or treated with 1% NP-40 for 30 min on ice and
oncentrated in a Centricon YM-100 filter unit, except for Cav-2, for which
2% SDS-PAGE, followed by immunoblotting with antibodies against NS3,
from top to bottom (light to heavy).
Fig. 2. Detergent solubilization of HCV proteins in HCV replicon cells. Cell lysates were untreated, treated with 1% TX-100 on ice, 1% TX-100 at 37 jC, or 60
mM octylglucoside on ice, and fractionated by discontinuous sucrose gradient centrifugation. Each fraction was concentrated in a Centricon YM-30 filter unit.
Equal volumes of the recovered fractions were analyzed on a 12% SDS-PAGE, followed by immunoblotting with antibodies against NS5A, Calnexin, or Cav-2.
Fractions are numbered from 1 to 9 in order from top to bottom (light to heavy).
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structures have properties of lipid rafts. Furthermore, these
membrane structures are distinct from the ER membrane.
Detergent solubilization of HCV proteins in HCV replicon
cells
To confirm that HCV NS proteins are associated with
lipid rafts, cell lysates were treated with 1% Triton X-100
(TX-100) on ice before equilibrium flotation centrifugation;
each fraction was concentrated by passing through a Cen-
tricon YM-30 filter unit. Immunoblotting analysis showed
that both NS5A and Cav-2 were recovered exclusively in
the membrane-containing fractions even after TX-100 treat-
ment at 4 jC. In contrast, the ER protein Calnexin was
solubilized by TX-100 (Fig. 2). However, after treatment
with h-octylglucoside at 4 jC or TX-100 at 37 jC, the
association of NS5A or Cav-2 with DRM structure was
disrupted, as was observed for other raft-localized proteins
(Brown and Rose, 1992). NS3 and NS5B were also shifted
to the detergent-soluble fractions after treatment with h-
octylglucoside at 4 jC or TX-100 at 37 jC (data not
shown). Calnexin was solubilized by detergents under any
one of these conditions. These results are consistent with the
interpretation that the DRM structures containing the HCV
NS proteins are lipid rafts.
Cholesterol sequestration assay
As a more stringent test for the association of HCV NS
proteins with lipid rafts, we analyzed the effect of choles-
terol disruption on the buoyant property of the NS proteins.
It has been shown that the insolubility of lipid rafts in TX-
100 on ice depends on cholesterol (Chamberlain et al.,
2001), and that the removal of cholesterol from raft leadsFig. 3. Cholesterol dependence of raft association of HCV NS proteins. Cell lysat
saponin on ice and fractionated by discontinuous sucrose gradient centrifugation. Nto dissociation of the raft proteins from the lipid (Simson et
al., 1998). When replicon cell lysates were treated with a
combination of saponin (pore-forming agent) and 0.5% TX-
100 at 4 jC to disrupt cholesterol (Chamberlain et al.,
2001), NS5A protein was effectively solubilized and no
longer exhibited buoyancy in sucrose gradients (Fig. 3). As
shown above (Fig. 2), in the presence of 0.5% TX-100 alone
without saponin at 4 jC, most of the NS5A proteins
remained in the membrane fraction. NS5B protein was also
solubilized by saponin plus TX-100 (data not shown). The
cholesterol-dependent insolubility of NS proteins further
indicates that these proteins are associated with cholester-
ol-rich lipid rafts.
Both HCV positive- and negative-strand RNAs exist in DRM
fraction in Huh-7/replicon cells
We next examined the association of HCV RNA with
cellular membranes. We utilized tagged reverse trascriptase-
polymerase chain reaction (RT-PCR) for detection of ()
and (+)-strand HCV RNA in the membrane flotation su-
crose fractions. Strand specificity was examined using
serially diluted synthetic (+) and ()-strand HCV RNAs.
Under these conditions, PCR detection was very strand-
specific; even after 35 cycles of PCR amplification, no (+)-
strand RNA could be detected using the ()-strand-specific
probe, although 106 copies of ()-strand RNA could be
detected (Fig. 4A). Conversely, (+)-strand-specific probe
could distinguish (+) from ()-strand RNA by at least 2
logs at 25 cycles of PCR amplification (Fig. 4B). Using
these PCR conditions, ()-strand RNA was detected in the
membrane fractions 2–4, with the intensity comparable to
that of 106 copies of ()-strand RNA (Fig. 4A). (+)-strand
RNA was detected after 25 cycles of PCR amplification in
the membrane fractions 2 and 3, with an intensity compa-es were treated with either 0.5% TX-100 (control) or 0.5% TX-100 + 0.5%
S5A and Cav-2 proteins were analyzed as described in the legend of Fig. 2.
Fig. 4. Strand-specific RT-PCR assay to detect negative- and positive-strand RNAs in the RC. Negative (A)- and positive (B)-strand RNAs were analyzed by
using the tagged RT-PCR method. PCR was conducted for one round of 30, 35 cycles or 20, 25 cycles for negative- and positive-strand RNA, respectively,
followed by agarose gel electrophoresis. Synthetic positive- and negative-strand RNAs were prepared and diluted to 104, 105, 106, 107, 108 copies per reaction
with total cellular RNA of Huh-7 cells as positive and negative controls. Cell lysates were fractionated by discontinuous sucrose gradient centrifugation. Total
RNA was extracted from equal volumes of the recovered fractions. Fractions are numbered from 1 to 9 in order from top to bottom (light to heavy).
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Thus, ()-strand RNAwas present in approximately 10-fold
lower molar amount than that of (+)-strand RNA, consistent
with the previous report for the amounts of the HCV
replicative intermediate in the replicon cells (Bartenschlager
and Lohmann, 2000). Although this assay system is only
semiquantitative within a narrow range, the result was
highly reproducible. These results demonstrated that the
membrane complex contained HCV RNA replication
intermediates.
Characterization of the structure of the RCs
To characterize the structure of RCs, we first examined
the RNase sensitivity of HCV RNA in the membrane
fractions before and after treatment with detergents. The
fractions separated by membrane flotation gradients were
treated with 150 or 1000 ng/ml of RNase A under low-salt
buffer conditions. The results showed that HCV RNA in
fractions 1–5 was mostly resistant to RNase A treatmentFig. 5. RNase sensitivity of HCV RNA in the RC. Cell lysates were untreated, or tr
jC for 30 min, and fractionated by discontinuous sucrose gradient centrifugation. E
room temperature. The digestion was terminated by phenol extraction. HCV RN
electrophoresis. Fractions are numbered from 1 to 9 in order from top to bottomeven after the membrane fraction had been treated with 1%
NP-40 at 4 jC (Fig. 5). The distribution of HCV RNA
treated with NP-40 was slightly narrower than that of the
untreated sample (Fig. 5) and was consistent with the
distribution of the NS proteins (Fig. 1). After treatment with
either h-octylglucoside at 4 jC or TX-100 at 37 jC, the
HCV RNAwas completely digested by RNase (150 ng/ml).
These data suggested that HCV RNAs were mostly enclosed
within the DRM structures.
We next examined whether the HCV NS proteins were
also enclosed within lipid rafts. We performed trypsin
treatment of membrane fractions containing HCV NS
proteins. As shown in Fig. 6, in the absence of detergent
treatment, most of the NS5B protein was resistant to
trypsin digestion even at a very high concentration of
trypsin (100 Ag/ml). After the membrane was treated with
NP-40 at 4 jC, at least some NS5B was not digested. In
contrast, after treatment with TX-100 at 37 jC, NS5B
was completely digested by trypsin (100 Ag/ml). This
result suggested that at least part of NS5B was protectedeated with 1% NP-40 on ice, 60 mM octylglucoside on ice, or TX-100 at 37
ach fraction was incubated with 150 or 1000 ng/ml of RNase A for 5 min at
A was detected by RT-PCR method and fractionated by 2% agarose gel
(light to heavy).
Fig. 6. Protease sensitivity of the HCV NS protein in the RC. Cell lysates were fractionated by flotation sucrose gradient centrifugation. Each fraction was
concentrated in a Centriplus YM-100 filter unit. Fraction 2, which contains HCV proteins, was incubated without or with 1% NP-40 at 4 jC or 1% TX-100 at
37 jC for 1 h. Then samples were incubated without or with either 10 or 100 Ag/ml of Trypsin for 5 min on ice. The digestion was terminated by adding
soybean trypsin inhibitor and analyzed on a 12% SDS-PAGE with monoclonal antibody against NS5B.
Fig. 7. Characterization of RNA synthesized from the endogenous
templates in HCV RCs. Huh-7/replicon and Huh-7/Neo (mock) cells were
fractionated by discontinuous sucrose gradient centrifugation as described
in Materials and methods. Each fraction was concentrated in a Centricon
YM-30 filter unit. Equal volumes of the recovered fractions were analyzed
on a 12% SDS-PAGE, followed by immunoblotting with monoclonal
antibody against NS5B (A). Each fraction isolated from Huh-7/replicon (B),
Huh-7/Neo (control cell) (C), and Huh-7/replicon treated with TX-100 on
ice for 1 h (D) was analyzed in a replication assay that included [a-32P]
CTP. RNA was extracted from each fraction and analyzed on a 1%
methylmercury agarose gel and autoradiographed. An in vitro transcribed
replicon RNA was used as an RNA marker (Replicon ss RNA). Fractions
are numbered from 1 to 9 in order from top to bottom (light to heavy).
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but the protection may not be complete.
DRM fractions are active in HCV RNA synthesis
To determine whether the RCs contained all the compo-
nents for RNA synthesis, each fraction from the membrane
flotation gradient was used for in vitro RNA synthesis using
the endogenous viral RNA template. As shown in Fig. 7A,
HCV NS5B was predominantly present in fraction 2, with a
lesser amount in 3, 5, and 6 (Fig. 7A). Each fraction was
added to a replication assay mixture containing [a-32P] CTP
and incubated at 30 jC for 4 h. RNA was purified from the
reaction mixture, denatured and analyzed by denaturing
methylmercury agarose gel electrophoresis. A radiolabeled
RNA species, which corresponded in size to that of the
replicon RNA (8 kb), was detected in fraction 2 (Fig. 7B). A
very weak signal was also detected in fraction 3. No RNA
product was detected in fractions 5 and 6, although they
contained some NS5B. These results indicate that fraction 2
contained the active RCs, whereas NS5B in fractions 5 and
6 were not in the active RCs. No radiolabeled RNA product
corresponding to the template size was detected when
fractions derived from mock Huh-7/Neo cells were used
(Fig. 7C).
To determine whether these membranes were lipid rafts,
the flotation gradients were prepared after the cellular
lysates were treated with TX-100 4 jC for 1 h. Again, the
radiolabeled RNA product was detected in DRM fraction 2
(Fig. 7D). These data suggested that the active HCV RCs
are present in DRM fractions.
Subcellular locolization of RCs
To further analyze the nature of membrane locolization
of RCs, lysates were examined by a subcellular membrane
fractionation protocol (see Materials and methods) that can
separate the ER from the Golgi. The trans-Golgi marker,
Syntaxin 6, and the ER marker, calnexin, were partially
separated under these conditions and were detected in
fractions 2–4 and fractions 4–9, respectively (Fig. 8A).
Significantly, most of NS5A and NS5B were detected in
fractions 1–3, more closely resembling the distribution of
syntexin 6. However, a significant portion of NS5A also
overlapped with the distribution of calnexin. Each fraction
was then subjected to in vitro RNA replication assay. Usingthis fractionation protocol, the in vitro RNA replication
activity was relatively weak; nevertheless, the radiolabeled
RNA product was detected only in fractions 1 and 2 (Fig.
8B). These data suggested that NS proteins were distributed
Fig. 9. Effects of cholesterol reduction on viral RNA replication. Cells
were cultured in medium that contained 10% delipidated calf serum and 5
AM of lovastatin for 18 h. For control, cells were cultured in DMEM with
10% FBS. Total cellular cholesterol levels were measured (A). Quantifi-
cation of HCV RNA in the cells was calculated by real-time RT-PCR
method (B). GAPDH mRNA was used as the internal control. Error bars
denote standard deviations with asterisks indicating statistical significance
(*P < 0.05; **P = 0.01).
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RCs were found only in the Golgi-derived membranes, but
not the ER fractions.
Effect of cholesterol depletion on replication of HCV
replicon in Huh-7/replicon cells
Cholesterol sequestration assay (Fig. 3) suggests that
the integrity of the lipid raft containing the NS protein
depends on cholesterol. To examine the role of cholesterol-
rich rafts in HCV replication, we treated replicon cells with
5 AM of lovastatin, which is an HMG-CoA reductase
inhibitor, to decrease cellular cholesterol synthesis, and
cultured the cells in the medium containing 10% delipi-
dated calf serum (see Materials and methods). This treat-
ment reduced cellular cholesterol levels by an average of
35% (Fig. 9A). Under the same condition, the growth and
viability of cells were not altered when compared with the
control cells for up to 18 h; however, longer treatment (24
h) caused slight reduction in cell growth rate (data not
shown).
To determine the effect of cholesterol reduction on
HCV RNA replication, HCV RNA titer in the replicon
cells was measured in control and cholesterol-reduced
replicon cells. The real-time PCR assay for HCV RNA
used in this study showed linearity over a range of 106–
101 copies per reaction and the correlation coefficient of
the analysis was maintained above 0.96 for all experi-
ments. Fig. 9B shows that HCV RNA titer was reduced by
approximately 45% in the cholesterol-reduced cells,Fig. 8. Separation of membranes from the replicon cells. Cell lysates were
fractionated to separate the ER and the Golgi by discontinuous sucrose
gradient centrifugation as described in Materials and methods. (A) Each
fraction was concentrated in a Centricon YM-10 filter unit and analyzed by
immunoblotting with antibody against NS5A, NS5B, Calnexin, and
Syntaxin 6. (B) In vitro replication assay of each fraction as in A. The
RNA products were autoradiographed.corresponding to the level of reduction of cholesterol under
the same condition.Discussion
HCV RNA replication occurs on the intracellular mem-
brane (Bartenschlager and Lohmann, 2000), similar to the
schemes utilized by other RNA viruses. Shi et al. (2003)
reported that the newly synthesized, metabolically labeled
HCV RNA in HCV subgenomic replicon cells was localized
to distinct speckle-like structure, which may be equivalent
to the membranous web, as reported by Gosert et al. (2003).
In the present study, we characterized enzymatically active
RCs by biophysical methods. The nature of the speckles was
revealed to consist of lipid rafts and to be highly resistant to
detergent.
Lipid rafts are known to play an important role in virus
entry and virus assembly of many viruses, for example,
influenza virus (Barman et al., 2001; Scheiffele et al., 1999;
Zhang et al., 2000), human immunodeficiency virus type-1
(HIV-1) (Ding et al., 2003; Manes et al., 2000; Ono and
Freed, 2001), Ebola, Marburg virus (Bavari et al., 2002),
enterovirus (Stuart et al., 2002), avian sarcoma and leukosis
virus (Narayan et al., 2003), Coxsackie B virus, adenovirus
(Ashbourne Excoffon et al., 2003), measles virus (Manie et
al., 2000), and respiratory syncytial virus (Brown et al.,
2002). However, HCV is the first example of the association
of lipid raft with viral RNA replication.
The results of our studies appear to be at odds with a
reported study showing that NS proteins were associated
with the ER in another replicon system (El-Hage and Luo,
Fig. 10. A proposed model for the formation of HCV RC on lipid rafts.
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et al., 2001). The difference between the localization pat-
terns of NS proteins in our studies and the previous reports
may be attributed to the proportion of NS proteins existing
in lipid rafts. When NS proteins are expressed alone, they
are localized primarily in the ER. Most likely, they became
relocalized to lipid raft membrane only when they are
actively engaged in RNA replication. Thus, the proportion
of NS proteins in lipid raft may correlate with the degree of
RNA synthesis in the cells. We have established several
replicon cell lines from different sources. Indeed, the pro-
portion of NS5B protein associated with lipid rafts was
variable in different replicon cell lines (data not shown).
Furthermore, HCV RNA titers in different replicon cell lines
appear to correlate with the amount of NS5B in lipid raft
(data not shown). These results suggested that lipid raft
might have an important role in HCV replication.
Expression of Cav-2, which is associated with lipid rafts,
in Huh-7 cells was very low (Vainio et al., 2002); in
contrast, the Cav-2 level in Huh-7/replicon was more than
four times higher than that in Huh-7 cells (data not shown).
These results suggested that our replicon cells might have
been selected for the enrichment of lipid rafts to support
HCV replication.
It is a widely held belief that the ER is the place where
all HCV actions occur (Gosert et al., 2003; Hijikata et al.,
1993; Mottola et al., 2002; Tu et al., 1999), but actual
HCV replication site has never been precisely determined.
We have previously shown by immunofluorescence studies
that newly synthesized, metabolically labeled HCV RNA,
together with all of NS proteins, were separated from the
ER, although some HCV NS proteins did reside in the ER
(Shi et al., 2003). In this report, we further showed by
membrane separation that HCV NS proteins existed in
both the ER and the Golgi, but HCV RNA replication
activity was detected mainly in the Golgi. Recently, Choi
et al. (2004) also found that the Golgi fraction, but not the
ER, was where active RCs existed. How RC-raft partic-
ipates in the life cycle of HCV is still not understood.
HCV RC rafts may be formed and traffick in a similar way
to other lipid rafts-binding proteins. Most likely, HCV NS
proteins are synthesized in the ER (Fig. 10A) and then
transported to the Golgi, where they distribute to lipid
rafts. The cholesterol-sphingolipid rafts are believed to
assemble in the Golgi, but not ER, because there is no
sphingolipid in the ER (Simons and Ikonen, 1997, 2000;
Simons and Toomre, 2000).
Our results of RNase and protease treatment suggested
that HCV RNA and at least some of NS proteins are
enclosed within the lipid rafts. We propose a model for
the formation of HCV RCs in the lipid rafts. All of HCV NS
proteins are synthesized in the ER (Fig. 10A). The NS
proteins and host proteins then are transported to Golgi,
where they associate with lipid rafts through protein–
protein and protein–raft interactions (Fig. 10B). Many
reports have demonstrated the interactions between HCVNS proteins (Bartenschlager and Lohmann, 2000; Bar-
tenschlager et al., 1994; Flajolet et al., 2000). Dimitrova et
al. (2003) suggested the existence of a complex network of
interactions implicating all NS proteins. We have previously
shown that NS5A bound to the C-terminus of a cellular
vesicle-associated membrane protein (VAP-33), whereas
NS5B protein bound to its N-terminus (Tu et al., 1999).
We have also found that VAP-33 is localized in both the raft
and non-raft membranes (Gao et al., 2004). Furthermore,
NS4B was completely associated with lipid raft even when
expressed alone, whereas NS3 or NS5B did not associate
with lipid rafts when expressed individually (Gao et al.,
2004) (Fig. 10B). NS5A was partially in the lipid raft.
However, when these proteins were expressed together, they
became colocalized in lipid raft. Therefore, NS4B, or its
precursor peptide, may be the key protein that binds to lipid
rafts first and then recruits other NS proteins sequentially to
form RCs (Fig. 10B).
The rafts have a highly dynamic nature to coalesce to
form the connected phase (Vaz and Almeida, 1993). NS4B
also may bind each other by its own affinity because
NS4B protein has an intrinsic ability to oligomerize
(Dimitrova et al., 2003) (Fig. 10C). As a result, the
connected phase of rafts may be stabilized. Indeed, clusters
of the same protein have been observed within the same
raft (Friedrichson and Kurzchalia, 1998; Varma and Mayor,
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have a short residency time in rafts, spending most of the
time outside rafts (Simons and Toomre, 2000). However,
clusters of transmembrane proteins may display a stronger
affinity for DRM because of an increased number of
binding sites per complex. Several papers have reported
that the protein affinity for rafts increased when the same
protein was crosslinked or otherwise oligomerized (Harder
et al., 1998; Janes et al., 1999; Ono and Freed, 2001;
Schutz et al., 2000). In the case of HCV, rafts themselves
may be stabilized and coalesced to form DRM domains by
the oligomerization of NS4B. The connected rafts, in turn,
facilitate recruitment and concentration of single RC to
form polymerized RCs.
Generally, the formation of invaginated pits on the
membrane and subsequent budding of vesicles is an ener-
getically demanding process (Ford et al., 2002). The forma-
tion of a new vesicle is thought to be driven by both the
polymerization of the coat protein into cage-like structure
and selection/modification of membrane lipid (Brodsky et
al., 2001; Ford et al., 2002; Schmidt et al., 1999). It was
reported that NS4B protein alone induced membranous web
in a membranous matrix (Egger et al., 2002) and that the
newly synthesized HCV RNA existed in these membranous
webs or speckles (Gosert et al., 2003; Shi et al., 2003).
These findings suggested that NS4B might modify mem-
brane curvature on binding lipid raft, in conjunction with
oligomerization of NS4B (Fig. 10D). During this process,
HCV RNA is enclosed within the membrane complex.
NS4B may also modulate the late steps in the vesicle
formation of RCs (Fig. 10E). Raft may modulate not only
the formation of polymerization platforms for RCs but also
vesicle formation of RCs. Polymerization platform model
has been proposed for a raft-binding toxin (Marquardt et al.,
1993) and for a raft-gag protein of HIV (Ono and Freed,
2001). With regard to the characteristic sizes of lipid raft
microdomains, suggestions range from associations of a few
molecules (Friedrichson and Kurzchalia, 1998) up to sizes
of several hundred nanometers (Edidin, 1997; Simson et al.,
1998; Yechiel and Edidin, 1987). Schutz et al. (2000)
showed that lipid raft domain had a size of 0.7 Am (0.2–
2.0 Am), which is compatible with the sizes of the speckles
and membranous webs observed for HCV RC (Gosert et al.,
2003; Shi et al., 2003).
Lai et al. (2003) demonstrated that HCV RC prepara-
tion could not use exogenous RNA as template and that
the newly synthesized single-strand RNA served as the
template for a further round of RNA synthesis. HCV
proteins have been shown to be relatively stable (Pietsch-
mann et al., 2001). Shi et al. (2003) suggested that HCV
RNA replication did not rely on continuous protein syn-
thesis. These data are consistent with our observation that
RCs were covered with lipid rafts so that exogenous RNA
could not be accessed by RCs. These NS proteins and
HCV RNA in RCs are thus capable of multiple rounds of
RNA synthesis.Rafts may move out of the Golgi towards the plasma
membrane, but may also move back to the ER (Brugger et
al., 2000). Cholesterol is recycled to the ER by retrograde
routes from the Golgi complex. The simian virus 40 uses
caveolae and cytoskeletal elements to transport from the
plasma membrane to the ER (Pelkmans et al., 2001).
Microtubule network is the presumed transport route for
vesicles trafficking. Bost et al. (2003) has suggested that
cytoskeletal elements are important for HCV RNA syn-
thesis in the HCV replicon cells. When HCV RC-raft
comes to the ER, the rafts are decomposed because of
the absence of sphingolipid in the ER. Conceivably, the
newly synthesized RNA are then released and used for
protein translation and for encapsidation with viral struc-
tural proteins.
Cholesterol can be released from the cell surface, at both
non-raft and raft domains, the latter potentially involving
caveolae (Simons and Ikonen, 1997, 2000; Simons and
Toomre, 2000). Pietschmann et al. (2002) showed that
HCV RNA in the replicon cells could be released into
supernatants in lipid-containing structures. We have also
found that some of RCs in our replicon cells are released
into the supernatant (data not shown). It is possible that
HCV uses the cholesterol–rafts circulation route to release
its RCs into the supernatant.
Our results suggest that HCV replication is associated
with lipid metabolism. Su et al. (2002) examined the host
response to HCV in infected chimpanzees at multiple time
points during the course of infection. Host genes involved in
lipid metabolism were found to be differentially regulated
during the early stages of infection. They also showed that
drugs affecting lipid biosynthetic pathways could regulate
HCV replication in HCV replicon system. HCV is known to
cause steatosis (Lai, 2002; Lerat et al., 2002; Negro, 2002).
The association of lipid raft with RNA replication thus may
explain partially the abnormality of lipid metabolism asso-
ciated with HCV infection.
In summary, we show here that HCV RNA and NS
proteins are associated with lipid rafts. This association is
likely to be a specific process that plays an important
role in the formation of HCV RCs. These findings will
facilitate further characterization of the components of
HCV RC. In addition, analysis of HCV–raft interaction
may provide new strategies for controlling HCV replica-
tion in vivo.Materials and methods
Cells
Huh-7 cells were grown at 37 jC in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) and nonessential amino acids. Huh-7/
replicon harboring an HCV subgenomic replicon RNA
derived from the HCV-N strain (Guo et al., 2001; Ikeda et
H. Aizaki et al. / Virology 324 (2004) 450–461458al., 2002) and Huh-7/Neo cells containing a neo gene were
grown in the same medium containing 0.5 mg/ml of G418
(Shi et al., 2003).
Antibodies
The primary antibodies used for the analyses in this
study were mouse anti-NS3 [Vector Laboratories (Burlin-
game, CA)], anti-NS5A [Biodesign (Saco, ME)], anti-
Cav-2 [New England Biolads (Beverly, MA)], anti-Syn-
taxin 6 [Stressgen (Victoric, BC, Canada)] monoclonal
antibodies and a rabbit anti-Calnexin polyclonal antibody
(Stressgen). The mouse monoclonal antibody against
NS5B was made by NS5B protein expressed from a
recombinant baculovirus and was a generous gift of Dr.
Soon Hwang (Hallym University, Korea) (Hwang et al.,
1997; Shi et al., 2003).
Membrane flotation, detergent solubilization, and
cholesterol sequestration assay
The membrane flotation assay was performed as previ-
ously described (Shi et al., 2003). Briefly, cells were first
lysed in 1 ml of hypotonic buffer [10 mM Tris–HCV (pH
7.5), 10 mM KCl, 5 mM MgCl2] and passed through a 25-
gauge needle 20 times. Nuclei and unbroken cells were
removed by centrifugation at 1000  g for 5 min in
microcentrifuge at 4 jC. Cell lysates were then mixed with
3 ml of 72% sucrose in low-salt buffer [LSB, comprising 50
mM Tris–HCl (pH 7.5), 25 mM KCl, and 5 mM MgCl2]
and overlaid with 4 ml of 55% sucrose in LSB, followed by
1.5 ml of 10% sucrose in LSB. The sucrose gradient was
centrifuged at 38000 rpm in a Beckman SW41 Ti rotor for
14 h for 4 jC. After centrifugation, 1-ml fractions were
taken from the top of the gradient, and each was added 1.7
ml of LSB to dilute sucrose and concentrated by being
passed through a Centricon YM-30 or Centriplus YM-100
filter unit (Millipore, Bedford, MA). One half of each
sucrose gradient fraction was separated by 12% SDS-PAGE
and transferred to nitrocellulose membrane. After blocking,
the membrane was incubated with the primary antibody for
1 h at 37 jC, followed by the appropriate species-specific
horseradish peroxidase conjugate, for an additional 1 h at 37
jC. Bound antibody was detected by the ECL-plus system
(Amersham, Piscataway, NJ).
To separate the ER from the Golgi fractions, membrane
flotation procedure was modified from the previous report
(Xu et al., 2003). Briefly, the cell lysates were fractionated
on a discontinuous sucrose gradient, which contained 1.5 ml
of 70% sucrose, 3.5 ml of 45% sucrose, 3.5 ml of 35%
sucrose, and 2.0 ml of 20% sucrose in LSB at 40 K rpm for
2 h. The fractions were diluted by LSB, concentrated by
passing through a Centricon YM-10 filter unit, and analyzed
by Western blotting and RNA replication assay.
To characterize lipid rafts, postnuclear supernatants of
cell lysates were treated with 1% NP-40 (Boehringer Man-nheim, Lavel, Quebec, Canada) at 4 jC, 1% TX-100
(Sigma-Aldrich, St. Louis, MO) at 4 jC, 1% TX-100 at
37 jC, or 60 mM h-octylglucoside (Calbiochem, La Jolla,
CA) at 4 jC for 1 h and followed by flotation centrifugation.
To disrupt lipid rafts, cell lysate was treated with saponin
(Sigma-Aldrich), which is a pore-forming agent. The cell
lysates were solubilized in either 0.5% TX-100 (control) or
0.5% TX-100+ 0.5% saponin for 1 h at 4 jC and followed
by flotation centrifugation.
Detection and quantitation of HCV RNA
To detect HCV RNA, RT-PCR was performed as previ-
ously described (Okamoto et al., 1990). HCV RNA was
extracted from one tenth of each sucrose gradient fraction
with the TRI Reagent (Molecular Research Center Inc.,
Cincinnati, OH). cDNA was synthesized by reverse tran-
scriptase (Invitrogen, Carlsbad, CA) using antisense primer
#36 as described. The PCR was performed with antisense
primer #36 and sense primer #32 for 30 cycles. Amplified
cDNA fragments were analyzed by electrophoresis on a 2%
agarose gel and ethidium bromide staining.
Negative-strand-specific RT-PCR was performed as pre-
viously described (Lanford et al., 1994). cDNAwas synthe-
sized by RT using a forward primer TF, which contained a
sequence unrelated to HCVat the 5V end (the tag) and the 5V-
untranslated sequences of HCV RNA at the 3V end, and
followed by heat inactivation of the RT for 1 h at 100 jC.
The cDNA was amplified by 30 or 35 cycles of PCR using
primer pairs of T (the tag sequence) and #36. PCR products
were analyzed by electrophoresis on a 2% agarose gel and
ethidium bromide staining.
Positive-strand-specific RT-PCR was modified from the
negative-strand-specific PCR method. Briefly, cDNA syn-
thesis was performed by RT using reverse primer #T36 (5V
TCATGGTGGCGAATAAAACACTAC TCGGCTAGC
AGT 3V), which contained a sequence unrelated to HCVat the
5V end (the tag) and the 5V-untranslated sequences of HCVat
the 3V end, and followed by heat inactivation of the RT for 1
h at 100 jC. The cDNAwas amplified by 20 or 25 cycles of
PCR using the primer pairs of Tand #32. Strand-specific PCR
assays were controlled by amplification of 104, 105, 106, 107,
and 108 copies of the correct and the complementary strands
of synthetic HCV RNA mixed with total cellular RNA of
Huh-7 cells as positive and negative controls, respectively.
To determine the quantity of RNA by real-time PCR, we
performed a single-tube reaction by using the TaqMan EZ
RT-PCR Core Reagents (Applied Biosystems, Foster City,
CA). Duplicate reactions for RNA standards and the samples
were performed in 20-Al volume using 1.0 Al of HCV RNA,
primers from HCV 5V non-coding region (5V GAG TGT CGT
GCAGCCTCCA 3V and 5VCACTCGCAAGCACCCTAT
CA 3V) of the HCV 1b sequence (Okamoto et al., 1992), and a
fluorescent probe [5V (FAM) CCC GCA AGA CTG CTA
GCC GAG TAG TGT TGG (TAMRA) 3V] spanning these
two regions. The RT step was performed at 60 jC for 50 min,
H. Aizaki et al. / Virologyfollowed by 1 min at 50 jC. The amplification condition was
as follows: 95 jC for 5 min and 50 cycles of denaturation at
94 jC for 15 s, annealing at 55 jC for 10 s, and extension at
69 jC for 1 min.
Using the ABI Prism 7900 program, standard curves of
the assays were obtained automatically by plotting the three
hold values against each standard dilution of known con-
centration (101–106 copies per reaction) of HCV genotype
1b transcript. The same software was used to calculate the
coefficients of regression. Using a standard curve, the
Sequence Detector software calculated automatically the
concentration of RNA copies in the experimental samples
according to their three hold valves. Values were normalized
to that of GAPDH (Applied Biosystems). Each test was
done in triplicate and averages were obtained.
RNase treatment
One tenth of each sucrose gradient fraction was treated
with 150 or 1000 ng/ml of RNase A (Ambion, Austin, TX)
for 5 min at room temperature under the low-salt condition
(30 mM NaCl, 3 mM sodium citrate). Following treatment,
the RNA in the digestion mixture was purified with the TRI
Reagent and precipitated. The samples were analyzed by
RT-PCR.
Proteinase digestion assay
Proteinase digestion assay was performed as described
previously (Polyak et al., 1998). After the membrane
flotation assay, the membrane fraction 2 was treated with
1% NP-40 at 4 jC or 1% TX-100 at 37 jC for 1 h. Samples
were incubated with or without trypsin (10, 100 Ag/ml) at 4
jC for 5 min. The reactions were stopped by adding 100 Ag/
ml of soybean trypsin inhibitor. Then samples were ana-
lyzed by immunoblotting.
RNA replication assay
The RNA replication assay was similar to that described
before (Bienz et al., 1992). Briefly, 20 Al of each sucrose
gradient fraction was added to the following reagents in a
final volume of 50 Al: 50 mM HEPES (pH 7.6), 10 mM
dithiothreitol, 3 mM MgCl2, 1.0 mM GTP, 1.0 mM ATP, 1.0
mMUTP, CTP to 0.04 mMwith [a-32P] CTP (Amersham) at
400 Ci/mmol and 0.1 mM unlabeled CTP, 10 Ag of actino-
mycin D per milliliter, 25 Ag of creatine phosphokinase per
milliliter (Roche, Indianapolis, Ind.), 5 mM creatine phos-
phate (Roche), 800 U of RNase inhibitor per milliliter
(Promega Corporation, Madison, WI), and 50 mM potassium
acetate. The mixture was incubated at 30 jC for 4 h.
Extraction of RNA from the total mixture was performed
with the TRI Regent. The RNAwas precipitated and eluted in
10 Al of RNase-free water. The replication products were
analyzed by methylmercury agarose gel electrophoresis as
described previously (Bailey and Davidson, 1976).Cholesterol depletion assay
Cells were grown on six-well trays in DMEM supple-
mented with 10% delipidated calf serum and 5 AM of
lovastatin (HMG-CoA reductase inhibitor) (Sigma) for 18
h. For control, cells were cultured in DMEM with 10% FBS.
Total cellular cholesterol levels were measured by using
Amplex Red Cholesterol Assay Kit (Sigma), which is based
on an enzyme-coupled reaction that detected both free
cholesterol and cholesteryl esters. Cell viability was
assessed by Trypan Blue exclusion.
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